Multiple hemopoietic defects and lymphoid hyperplasia in mice lacking the transcriptional activation domain of the c-rel protein

被引:53
作者
Carrasco, D
Cheng, J
Lewin, A
Warr, G
Yang, HY
Rizzo, C
Rosas, F
Snapper, C
Bravo, R
机构
[1] Bristol Myers Squibb Pharmaceut Res Inst, Dept Oncol, Princeton, NJ 08543 USA
[2] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Microbiol, Wallingford, CT 06492 USA
[3] Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20814 USA
关键词
D O I
10.1084/jem.187.7.973
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The c-rel protooncogene encodes a member of the Rel/nuclear factor (NF)-kappa B family of transcriptional factors. To assess the role of the transcriptional activation domain or c-Rel in vivo, we generated mice expressing a truncated c-Rel (Delta c-Rel) that lacks the COOH-terminal region, but retains a functional Rel homology domain. Mice with an homozygous mutation in the c-rel region encoding the COOH terminus of c-Rel (c-rel(Delta CT/Delta CT)) display marked defects in proliferative and immune functions, c-rel(Delta CT/Delta CT) animals present histopathological alterations of hemopoietic tissues. such as an enlarged spleen due to lymphoid hyperplasia, extramedullary hematopoiesis, and bone marrow hypoplasia. In older c-rel(Delta CT/Delta CT) mice, lymphoid hyperplasia was also detected in lymph nodes, liver, lung, and stomach. These animals present a more severe phenotype than mice lacking the entire c-Rel protein. Thus, in c-rel(Delta CT/Delta CT) mice, the lack of c-Rel activity is less efficiently compensated by other NF-kappa B proteins.
引用
收藏
页码:973 / 984
页数:12
相关论文
共 57 条
[1]   SELECTION OF GENETIC-VARIANTS OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS IN SPLEENS OF PERSISTENTLY INFECTED MICE - ROLE IN SUPPRESSION OF CYTO-TOXIC LYMPHOCYTE-T RESPONSE AND VIRAL PERSISTENCE [J].
AHMED, R ;
SALMI, A ;
BUTLER, LD ;
CHILLER, JM ;
OLDSTONE, MBA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (02) :521-540
[2]   Genetic approaches to study Rel/NF-kappa B/I kappa B function in mice [J].
Attar, RM ;
Caamano, J ;
Carrasco, D ;
Iotsova, V ;
Ishikawa, H ;
Ryseck, RP ;
Weih, F ;
Bravo, R .
SEMINARS IN CANCER BIOLOGY, 1997, 8 (02) :93-101
[3]   NF-kappa B: Ten years after [J].
Baeuerle, PA ;
Baltimore, D .
CELL, 1996, 87 (01) :13-20
[4]  
BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
[5]   The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[6]   An essential role for NF-kappa B in preventing TNF-alpha-induced cell death [J].
Beg, AA ;
Baltimore, D .
SCIENCE, 1996, 274 (5288) :782-784
[7]   THE REL FAMILY - MODELS FOR TRANSCRIPTIONAL REGULATION AND ONCOGENIC TRANSFORMATION [J].
BOSE, HR .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1114 (01) :1-17
[8]   THE MOUSE C-REL PROTEIN HAS AN N-TERMINAL REGULATORY DOMAIN AND A C-TERMINAL TRANSCRIPTIONAL TRANSACTIVATION DOMAIN [J].
BULL, P ;
MORLEY, KL ;
HOEKSTRA, MF ;
HUNTER, T ;
VERMA, IM .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (10) :5473-5485
[9]   NEUTROPHIL AND B-CELL EXPANSION IN MICE THAT LACK THE MURINE IL-8 RECEPTOR HOMOLOG [J].
CACALANO, G ;
LEE, J ;
KIKLY, K ;
RYAN, AM ;
PITTSMEEK, S ;
HULTGREN, B ;
WOOD, WI ;
MOORE, MW .
SCIENCE, 1994, 265 (5172) :682-684
[10]  
CARRASCO D, 1994, DEVELOPMENT, V120, P2991